Mark M. Kowalski
Chief Tech/Sci/R&D Officer at EUPRAXIA PHARMACEUTICALS INC.
Net worth: 25 920 $ as of 2024-03-30
Network origin in Mark M. Kowalski first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Extinct | Biotechnology | 21 | |
| Public Company | Biotechnology | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark M. Kowalski via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | General Counsel Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member General Counsel | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
| CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer Chief Operating Officer Public Communications Contact | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member Founder Chief Executive Officer | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Masters Business Admin | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Founder Chief Executive Officer Public Communications Contact | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree | |
| Queen's University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| Simon Fraser University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
| University of Victoria | College/University | Masters Business Admin Undergraduate Degree | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Chairman Chairman | |
Vancouver Aquarium
 Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Part of Herschend Family Entertainment Corp., Vancouver Aquarium operates an aquarium. The private company is based in Vancouver, Canada. Vancouver Aquarium was acquired by Herschend Family Entertainment Corp. from Ocean Wise Conservation Association on April 15, 2021. The Canadian company was founded in 1951. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Biotechnology | Chairman Director/Board Member | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Public Communications Contact Human Resources Officer | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Sales & Marketing | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Chairman | |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Accuro Technologies, Inc. | Director/Board Member Chairman Chief Executive Officer | ||
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Junior Achievement British Columbia | Director/Board Member Director/Board Member | ||
| NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PERIMETER MEDICAL IMAGING AI, INC. | Medical Specialties | Director/Board Member Investor Relations Contact | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member Director/Board Member |
Statistics
International
| United States | 28 |
| Canada | 20 |
| United Kingdom | 4 |
| Bermuda | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Finance | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 303 |
| Corporate Officer/Principal | 118 |
| Independent Dir/Board Member | 85 |
| Chairman | 61 |
| Chief Executive Officer | 58 |
Most connected contacts
| Insiders | |
|---|---|
| James Topper | 49 |
| Paul Geyer | 37 |
| Donald Parfet | 31 |
| Ken Galbraith | 30 |
| Richard Glickman | 26 |
| Simon Pimstone | 22 |
| John Montalbano | 22 |
| Gaurav Aggarwal | 21 |
| Craig Collard | 18 |
| Andrew Allen | 18 |
| Georgia Erbez | 18 |
| Nicole Onetto | 17 |
| Michael Jeffrey Abrams | 16 |
| Richard Henriques | 15 |
| Adam Daniel Cutler | 15 |
- Stock Market
- Insiders
- Mark M. Kowalski
- Company connections
